However, given the very limited size of the evidence-base in support of IGRAs to date and the vulnerability of these patients to develop severe and disseminated forms of TB on TNF blockade, it may be prudent to perform TST in parallel with IGRA to maximise the diagnostic sensitivity of screening, at least until the IGRA evidence-base in this population has expanded sufficiently. This evidence concerns the gene TNF and tuberculosis.